Ketamine: The Effects On Your Body And Mind Following An Infusion

Ketamine: The Effects On Your Body And Mind Following An Infusion

Last reviewed and updated: June 30, 2026.

Key Takeaways

During infusionDissociation, perceptual changes, possible nausea โ€” typically 40โ€“90 min; BP elevation (20โ€“40 mmHg); constant monitoring
The integration window24โ€“72 hrs post-infusion; neuroplasticity elevated; best time for therapy, journaling, reflection โ€” actively use this window
Afterglow1โ€“4 days of improved mood and reduced rumination โ€” the therapeutic opportunity; engage deliberately, donโ€™t let it pass
Physical effectsBP rise, possible nausea (now managed with ondansetron); HR changes; no respiratory depression at therapeutic doses
What shapes the experienceDose, infusion speed, setting, and pre-infusion anxiety โ€” preparation reduces anxiety and consistently improves the experience

New advances in medicine have led to psychedelic therapy growing in popularity. One of those psychedelics, ketamine โ€” which first began trials in 1964 โ€” is becoming an increasingly popular, with many wondering how ketamine effects the mind and body.

The number of ketamine clinics popping up attests to its popularity in the healthcare sector. And, as with many (if not all) other medications, there are ketamine effects to be aware of. Here, we explain the potential side effects of a ketamine infusion.

Looking for ketamine therapy? Click here to find top rated ketamine clinics near you

What Is Ketamine?

Ketamine is a drug that some physicians and veterinarians use to induce short-term dissociative anesthesia. Doctors usually administer it as an infusion directly into the bloodstream (IV).

The FDA approves many medications or drugs, meaning medical professionals can administer them for specific conditions. However, some of these drugs are off-label.

When a drug is off-label, it means a doctor uses it to treat a condition that it is not approved to treat.

Ketamine is one such drug: it is FDA-approved as an anesthetic, but many physicians administer it off-label. Rightly so, as several clinical trials and studies suggest that it could also help treat other conditions.

RELATED: How Psychedelics Helped a Father Overcome Unspeakable Grief

Depression

Researchers have several studies using ketamine for depression as a treatment option.

A 2019 study assesses the effect of a subanesthetic dose (i.e., a dose that would not cause anesthesia) of ketamine on subjects with severe depression. Results of the study show that symptoms of depression and anxiety improved significantly (almost immediately) after administering the first dose.

The drug has become a beacon of hope for many, as it is a potential option for treatment-resistant depression.

Ketamine also comes in the form of a nasal spray (Esketamine). The FDA approved it in 2019 for treating depression, but health practitioners should administer it in a healthcare setting.

RELATED: Watch Kevin Rose Talk to Tim Ferriss About His Ketamine Experience

Cancer Pain And Chronic Pain

Results of a review from 2021 suggest that ketamine shows promise for treating cancer-related pain. It found that ketamine effectively improved pain management, and it may also reduce a patientโ€™s need for morphine.

The use of ketamine for pain also reduces the need for opioids and, in turn, limits the adverse effects of opioids.

RELATED: Is Ketamine Therapy Right For You? Hereโ€™s What To Know

Potential Ketamine Effects Following An Infusion

While ketamine infusions are terrific because they work quickly, all drugs, including ketamine, have potential side effects. This is why patients should always take ketamine in a clinic setting.

But, even in a controlled environment, ketamine effects a handful of patients following an infusion. Common side effects include the following.

  • Dizziness
  • Nausea and vomiting
  • Raised blood pressure
  • Dissociation
  • Vertigo

However, side effects are limited when receiving a sub-anesthetic dose of ketamine.

A 2020 study looked at the adverse ways ketamine effects a person after a single dose for treatment-resistant depressions. The study results show that side effects โ€” such as feeling strange or loopy โ€” peaked at one hour and ultimately resolved after about two hours.

Researchers also note that serious adverse events were not present after subjects received a ketamine dose.

Looking for ketamine therapy? Click here to find top rated ketamine clinics near you

Can You Manage The Way Ketamine Effects You?

Ketamine is relatively safe to use in a clinical setting, as medical professionals can monitor patients.

Physicians can manage adverse ketamine effects if they become overwhelming in the following ways.

  • Monitoring the patientโ€™s breathing and circulation
  • Position them on their side or with their head facing downward when vomiting to prevent suffocation
  • Monitor the patientโ€™s vitals, and, if complications occur, they should be admitted for further observation

Generally, symptoms will resolve without intervention, and supportive care is not necessary.

While ketamine infusions are not without risk, we must weigh up its side effects against the risks associated with severe depression. The benefits of ketamine infusions far outweigh its risks, in contrast to the risks of treatment-resistant depression (which could ultimately lead to suicide).

RELATED: How Much Is Ketamine Therapy, And How Can You Pay?

The Addictive Potential Of Ketamine

The question of addiction hovers over any new drug, and, unfortunately, ketamine has addictive potential.

Unfortunately, ketamine is also common as a recreational drug. This is due to the โ€œhighโ€ feeling a person may experience. Although the recreational use of ketamine is on a small scale, it is not encouraged. It can lead to dire health consequences; such as bladder problems and liver injury.

An interesting fact, which may appear somewhat contradictory, is that ketamine may treat various addictions.

A review from 2018 delves into articles dealing with ketamineโ€™s ability to treat addiction. Although ketamineโ€™s efficacy for treating addiction needs further study, the results of the review are promising. The researchers found that ketamine prolonged abstinence from alcohol and heroin in alcoholics and heroin addicts.

Remember to proceed with caution before deciding to take ketamine. This is especially important for patients with a history of substance abuse. Medical professionals should only administer ketamine therapy after careful evaluation.

Can You Overdose On Ketamine?

Ketamine overdoses are not common, so limited data is available. Rare cases of ketamine overdoses are usually in conjunction with other drugs.

Physicians treat such patients with activated charcoal or address severe adverse effects with necessary medication.

Other Things To Know About How Ketamine Effects The Mind And Body

Before considering ketamine treatment, you need to consider the side effects associated with the drug. They are generally temporary but may be overwhelming to some individuals (especially if youโ€™ve never had similar medications).

When going for an infusion, ensure you have enough time because you may have to stay longer for observation depending on how your body reacts.

Also remember that ketamine has addictive potential, so have an in-depth discussion with your medical practitioner. Itโ€™s important to explore and weigh options for you before trying a ketamine infusion.

Ketamine for anxiety and depression does not have a standard regulation. This means each clinic has its own specifications for IV infusions, and there is no normal dose of ketamine for depressive patients.

Although studies on ketamine for other conditions is still in its infancy, it is picking up slowly. But, so far results are promising, as early research suggests ketamine infusions have a high success rate.

Above all, the most important consideration is only to allow a licensed medical professional to administer the drug to you in a controlled setting.

Updated Understanding of Ketamineโ€™s Effects: What 2024โ€“2025 Research and Clinical Practice Has Added

Our understanding of what happens to the body and mind during and after a ketamine infusion has sharpened considerably over the past two years, driven by formal research from academic centers and the accumulation of clinical experience across hundreds of ketamine clinics. This update covers the most clinically relevant advances โ€” with particular attention to the integration window, nausea management, cardiovascular monitoring, and what the afterglow period means for therapy.

The integration window is now a clinical standard, not an afterthought. The 24โ€“72 hours following a ketamine infusion represent a period of elevated neuroplasticity โ€” the brain is more malleable, more capable of forming new associations and breaking entrenched patterns. This is the mechanism behind ketamineโ€™s antidepressant effect, and it is also a window that can be actively used. Clinics following evidence-based protocols now routinely schedule integration sessions (with a therapist, counselor, or trained facilitator) within the first 24โ€“48 hours after each infusion. Research from groups including Yaleโ€™s Kwan Lab has shown that the combination of ketamine-induced synaptic changes and deliberate therapeutic work during this window produces substantially better long-term outcomes than ketamine alone. Journaling, intentional reflection, and even structured physical activity during this window appear to support the consolidation of therapeutic gains.

Nausea is now largely manageable โ€” and cardiovascular monitoring has tightened. One of the most common adverse effects of ketamine infusion is nausea, which historically affected a meaningful minority of patients during or shortly after infusion. Modern clinical practice now routinely administers ondansetron (Zofran) before the infusion, significantly reducing nausea incidence. Most patients who experienced nausea in earlier ketamine encounters will find it substantially reduced in contemporary clinical settings. On the cardiovascular side, ketamine reliably raises systolic blood pressure by 20โ€“40 mmHg and increases heart rate during the infusion โ€” these are expected pharmacological effects, not adverse events, but they require monitoring. Clinics have tightened pre-infusion cardiovascular screening in response to growing patient volume: patients with uncontrolled hypertension, recent cardiac events, or certain arrhythmias should discuss these factors with their provider before beginning a ketamine protocol.

The afterglow is real โ€” and how you use it matters. Most patients report a characteristic period of 1โ€“4 days following a ketamine infusion during which mood is lifted, rumination is quieted, and they feel more open, curious, and present. This is not the acute dissociative effect of the drug โ€” it emerges after those effects have fully cleared and reflects the downstream neurobiological changes, particularly increased BDNF (brain-derived neurotrophic factor) and synaptic density in prefrontal circuits associated with mood regulation. The afterglow is not permanent, but it is the therapeutic window where change is most accessible. Patients who use this period intentionally โ€” for difficult conversations, behavioral changes they have been avoiding, journaling about patterns they want to shift โ€” report that the antidepressant effects last longer. Patients who return to the same environment and habits without deliberate engagement may find the benefits fade more quickly. This is why the best clinical protocols treat the infusion as the beginning of a therapeutic episode, not the end of one.

Frequently Asked Questions

How long do the effects of a ketamine infusion last?

The answer depends on which effects you mean. The acute dissociative and perceptual effects during the infusion last 40โ€“90 minutes (the infusion duration) and resolve fully within 1โ€“2 hours of the infusion ending. A mild cognitive haze โ€” sometimes described as โ€œspacyโ€ or โ€œslowโ€ โ€” may persist for several hours, which is why patients should not drive the day of infusion. The therapeutic antidepressant effects are separate and emerge over the following hours to days: most patients notice mood improvement within 4โ€“24 hours after the infusion, and the peak benefit of a full 6-infusion protocol is typically felt 1โ€“2 weeks after completing the series. How long the antidepressant effects last varies significantly by individual: some patients maintain benefit for 3โ€“6 months, others begin to notice fading at 4โ€“6 weeks. Response durability often correlates with engagement in integration work during and after the protocol.

What does dissociation feel like during ketamine?

Dissociation during ketamine infusion is commonly described as a sense of distance or separation from your body and immediate surroundings โ€” as if observing yourself from a slight remove, or as if the usual sense of being โ€œinsideโ€ your body has loosened. Some patients describe it as floating, a dreamlike quality, or a feeling that thoughts are moving more slowly and from a greater distance. Perceptual effects may include visual distortion (patterns, colors appearing more vivid or unusual), altered time perception (minutes feeling like much longer), and occasionally mild auditory changes. The intensity of dissociation is dose-dependent and varies considerably between patients: some find it mild and pleasant, others find it initially disorienting. It is important to know that even at peak dissociation, patients remain aware that they are in a clinical setting and can communicate with staff. The experience typically resolves completely within 1โ€“2 hours after the infusion ends. Preparation โ€” knowing what to expect, choosing comfortable music and setting intentions beforehand โ€” consistently reduces anxiety and improves the experience.

Why do some people feel better immediately after ketamine?

The rapid onset of antidepressant effect โ€” sometimes within hours of the first infusion โ€” is one of ketamineโ€™s most distinctive and clinically important properties. The primary mechanism is ketamineโ€™s action on NMDA glutamate receptors, which triggers a cascade of synaptic changes: BDNF (brain-derived neurotrophic factor) is released, new synaptic connections form in the prefrontal cortex, and circuits associated with rumination and negative self-referential thinking are temporarily quieted. This is a fundamentally different mechanism from SSRIs, which require weeks of daily dosing to build antidepressant effect via serotonin system changes. Some patients feel relief almost immediately after the acute effects clear โ€” sometimes described as โ€œthe weight liftingโ€ or โ€œthe noise going quiet.โ€ This rapid response is particularly valuable for patients in acute crisis or those for whom weeks of SSRI trial-and-error would be dangerous. Not everyone experiences this immediate response; for some patients, the benefit builds across the infusion series.

What should you do in the 24 hours after a ketamine infusion?

The 24 hours following a ketamine infusion are the most neuroplastically active period โ€” the integration window โ€” and how you spend them matters. Most clinics now recommend: (1) Rest and gentle activity on the day of infusion; do not drive, operate machinery, or make major decisions; (2) Journal or reflect โ€” write down what came up during the infusion, any insights or images, themes that felt significant; this consolidates the experience and gives integration work something concrete to work with; (3) Schedule your integration session within 24โ€“48 hours if your protocol includes therapist support; (4) Avoid alcohol and cannabis for at least 24 hours, as both can blunt the neuroplastic window; (5) Notice your mood and thoughts โ€” if you feel unusually open, curious, or clear-headed, use that window deliberately; engage with things you have been avoiding, reach out to someone important, or begin a behavioral change you have been putting off. The afterglow period (1โ€“4 days of improved mood and reduced rumination) is not a passive benefit โ€” it is an opportunity that closes.

RELATED READING

Sian Ferguson

View all posts by Sian Ferguson

Sian Ferguson is a freelance writer based in Cape Town, South Africa and she has written for publications such as Healthline, Greatist, and Psych Central to name a few.

Her work focuses on health and wellness, and she's particularly passionate. She believes health content should inform and empower readers, not confuse them!

Dr. Ben Medrano

This post was medically approved by Dr. Ben Medrano

Dr. Ben Medrano is a board certified psychiatrist specializing in Integrative Psychiatry, Ketamine Assisted Therapy and Psychedelic Harm Reduction and Integration. He received his MD from the University of Colorado School of Medicine with additional training in the Urban Underserved Track (CU-UNITE). Dr. Medrano is most known for his work with ketamine assisted therapy and is the former Senior Vice President and US Medical Director of Field Trip Health - the largest in-office ketamine assisted therapy practice to date. He continues to sponsor Field Trip clinics as a local medical director at multiple sites on the East Coast allowing him to further the field of psychedelic assisted therapy and research.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Explore Psychedelic Therapy Regions